bRIGHT study 1-year data card
Brief outline of the 1-year data outcomes from the bRIGHT study evaluating the safety and effectiveness of TriClip™ TEER in patients with severe TR in a real-world, post-market setting.
LEARN MORE:
Related Resources
Valvular Heart Disease Guidelines at a Glance
Demonstrated Outcomes. Life-Changing Intervention
Reduced HF Hospitalisation. Improved Quality of Life
Immediate Relief. Durable Benefits
Tri.Fr 2 years outcomes
Navitor 5-years data from CRT
Tendyne expanded clinical study | PCR LV 2025
EXPAND G4 clinical data release | PCR LV 2025